Clinical trial
Registry of Central Sleep Apnea Patients Undergoing remedē System Implant
NCT07907068 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Registry of Central Sleep Apnea Patients Undergoing remedē System Implant
- Lead sponsor
- Zoll Medical Corporation
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 31, 2027
- Completion date
- May 31, 2037
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
central sleep apnea, central sleep apnea (diagnosis), central sleep apnea syndrome, sleep apnea, central
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Incidence of serious adverse events (SAEs) related to the remedē System implant procedure, device, or delivered therapy through 12 months post implant
Lead sponsor's other trials
Zoll Medical Corporation, most recent start first.
+30 more trials See the organization page
Similar trials
Same condition (Sleep Apnea, Central) and phase, most recent start first.
+32 more trials See the condition page